A number of cancer Twitter communities( #gyncsm, #bcsm, #btsm,#lcsm etc) are joining together for a chat on Biomarkers on Thursday, July 11, 2019 I hope some of my followers will join that chat at 8pm ET. pPathologist Dr. Timothy Craig Allen (@TimAllenMDJD) will be moderating the chat.Learn more by reading the post below by Janet Freeeman-Daily.
Until just a few years ago, chemotherapy was often the only option for some cancer patients. In just a
few short years, molecular therapies and immunotherapies have become commonplace as treatments
for cancer patients. But determining whether a particular cancer patient is a candidate for these new,
often very expensive, molecular and immunotherapies requires molecular biomarker testing. For manycancer patients and their families, the role of molecular biomarker testing in their diagnosis is a
unfamiliar and confusing. How is testing performed? How is the test result analyzed? What is involvedin getting helpful answers from biomarker testing? Does liquid biopsy have a role?
Pathologists are specialized doctors responsible for answering these questions. They identify any cancercells in the biopsied specimen, and guide the patient’s biomarker testing. Unfortunately, pathologists donot typically speak with patients, so patients and families–and even some doctors–often do not have aclear understanding of the role of molecular biomarker testing in the diagnosis and treatment ofcancers. Learning more about the basics of biomarker testing can help patients and families cut throughthe hype about biomarker testing, understand the patient’s specific disease more thoroughly, and learn what biomarker test results mean to the patient’s cancer treatment.
Please join moderator and pathologist Dr. Timothy Craig Allen (@TimAllenMDJD) at 8 PM Eastern Time
on Thursday, July 11, 2019, for a discussion about the basics of biomarker testing, a subject potentially
affecting all cancer patients and doctors. We will cover the following topics:
• T1: What is a biomarker and how is it identified?
• T2: What is biomarker testing and what is it used for?
• T3: What treatment options can be identified through biomarker testing?
• T4: What biomarker tests should be run for which types of cancers? What is a liquid
biopsy and when is useful?
• T5: Can and should patients pursue biomarker testing for treatment options if their
doctor does not offer it?
Please remember to include #cancersm in ALL your tweets so the other chat participants can see them.
If you need a refresher, read the #LCSM primer on participating in a Twitter chat (the hashtag in your
tweets will be #cancersm, not #LCSM). Note that some tweetchat apps (like tchat.io) will not display
tweets longer than 140 characters. Hope you’ll join us!
Every Day is a Blessing!
Tuesday, July 9, 2019
Saturday, July 6, 2019
I am so pleased to have co-authored and to have the #gyncsm community and chat be a part of a newly published article in the JCO Clinical Cancer Informatics journal.